European Archives - Page 859 of 1452 - European Medical Journal

Sustainable solutions for a greener tomorrow

From drug development to disposal, how can all processes and functions be considered through a greener lens, and work towards a healthier and safer future?

IS mRNA the future of vaccine technology?

The mRNA COVID-19 vaccine took only a year to develop – beating the previous fastest traditional vaccine development, held by the 1967 mumps vaccine, of four years. How does it differ from traditional vaccine technology?

Tamika Jean Baptiste

Tamika Jean-Baptiste on diversity and inclusion

Tamika Jean-Baptiste, Vice President and Chief Diversity Officer, Amgen, discusses her lifelong passion for diversity.

Association Between a Synthetic Progestogen and Cancer Risk in Offspring

A team of researchers investigated the relationship between in utero exposure to 17-OHPC and likelihood of cancer in offspring…

New Study to Investigate Long-Term Effects of COVID-19 in Pregnancy

ALTHOUGH the overall risk is low, people who are pregnant or were recently pregnant are at an increased risk of severe illness from COVID-19…

Migratory Loose Bodies from the Ankle Joint into the Flexor Hallucis Longus Tendon Sheath

Communication between the flexor hallucis longus (FHL) tendon sheath and the ankle joint is well-recognised and is reportedly present in around 17% of individuals.

New Information on How COVID-19 Affects Human Kidney Cells

The researchers discovered that although the virus enters, infects, and replicates in human kidney cells, this did not always lead to cell death…

Is Coffee Consumption Associated with Risk of Chronic Kidney Disease?

Metabolites in the blood have been analysed, with their levels altered by coffee consumption, and an association with developing chronic kidney disease…

Replacing Hubris with Humility

A talk to Chip Helm, Author, and Account Executive, Cook Medical about leadership, personal branding, and how to sell yourself with humility.

EMJ Nephrology 9 [Supplement 4] 2021 Feature Image

EMJ Nephrology 9 [Supplement 4] 2021

CHRONIC kidney disease (CKD) affects approximately 700 million individuals worldwide. Many patients with CKD require haemodialysis, and more than two-thirds of these patients have CKD-associated pruritus (CKD-aP). CKD-aP can be bothersome for many patients and drastically affect quality of life, from causing sleep issues to mental health problems. Almost 40% of dialysis patients are at least ‘moderately’ bothered and 19% of patients are at least very much bothered by pruritus.